Medical Research Council - London Institute of Medical Sciences

Now in our 12th year of bringing you beautiful imagery from biomedical science every day

Antibiotic Overhaul
07 June 2015

Antibiotic Overhaul

Spectinomycin is an antibiotic, but not a very good one. Its weak antibacterial activity means it’s rarely ever used to treat patients with infections. But rather than consign it to the scrapheap, scientists have now given the drug a much-needed makeover. By computationally modelling the interaction of spectinomycin with its target – the bacterial protein synthesis machinery – the researchers were able to identify ways to chemically tinker with the drug’s structure, improving its bacteria-killing ability. In total, six new variants of the antibiotic were produced that were effective at killing a variety of common respiratory and sexually-transmitted bacteria. Indeed, while the old version of spectinomycin allowed this culture of human cells (stained green) to become overrun with Chlamydia trachomatis (orange), the revamped version of the drug almost entirely obliterated the bugs. The new improved suite of spectinomycins may thus serve as extra weapons in the continuing fight against antibiotic-resistant bacteria.

Written by Ruth Williams

Search The Archive

Submit An Image

What is BPoD?

BPoD stands for Biomedical Picture of the Day. Managed by the MRC London Institute of Medical Sciences the website aims to engage everyone, young and old, in the wonders of biomedicine. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.

Read More

BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.